Blue Water Vaccines Inc. Uncategorized Contracts & Agreements
21 Contracts & Agreements
- Form of Altos Warrants (Filed With SEC on September 24, 2024)
- Form of Inducement Letter (Filed With SEC on July 11, 2024)
- Form of Inducement PIO (Filed With SEC on July 11, 2024)
- Description of Registered Securities (Filed With SEC on April 11, 2024)
- Form of Stockholder Support Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix, and certain stockholders of Proteomedix (Filed With SEC on December 21, 2023)
- Form of Lock-Up Agreement, dated as of December 15, 2023, by and among Onconetix and certain stockholders of Proteomedix (Filed With SEC on December 21, 2023)
- Form of Letter Agreement (Filed With SEC on August 3, 2023)
- Form of Inducement PIO (Filed With SEC on August 3, 2023)
- Form of Inducement Letter (Filed With SEC on August 1, 2023)
- Form of Inducement PIO (Filed With SEC on August 1, 2023)
- Co-Development Agreement, dated February 1, 2023, between the Company and AbVacc, Inc (Filed With SEC on May 12, 2023)
- At-the-Market Offering Agreement, dated March 29, 2023 (Filed With SEC on March 29, 2023)
- Form of Wainwright Warrants by and among the Company and H.C. Wainwright & Co., LLC (Filed With SEC on August 11, 2022)
- Form of Preferred Investment Options, by and among the Company and the holders (Filed With SEC on August 11, 2022)
- Sponsored Research Agreement, effective as of June 30, 2022, by and between Blue Water Vaccines Inc. and Childrens Hospital Medical Center, d/b/a Cincinatti Childrens Hospital... (Filed With SEC on July 25, 2022)
- Amendment to Agreement for the Sponsorship of a Research Project, dated May 16, 2022 (Filed With SEC on June 1, 2022)
- Agreement for the Sponsorship of a Research Project, dated as of December 19, 2019, by and between Blue Water Vaccines Inc. and The Chancellor Masters and Scholars of the... (Filed With SEC on June 1, 2022)
- Form of Wainwright Warrants by and among the Company and H.C. Wainwright & Co., LLC (Filed With SEC on April 19, 2022)
- Form of Preferred Investment Options, by and among the Company and the holders (Filed With SEC on April 19, 2022)
- Description of Registered Securities (Filed With SEC on March 31, 2022)
- Letter Agreement between the Registrant and Ology Bioservices, Inc., dated as of January 9, 2020 (Filed With SEC on October 8, 2021)
